These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32317130)

  • 1. Performance characteristics of the high sensitivity Alinity i & ARCHITECT HBsAg Next Qualitative/Confirmatory assays.
    Sickinger E; Braun HB; Meyer T; Schmid K; Daghfal D; Oer M; Schultess J
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115033. PubMed ID: 32317130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ultra-sensitive Abbott ARCHITECT
    Lou S; Taylor R; Pearce S; Kuhns M; Leary T
    J Clin Virol; 2018 Aug; 105():18-25. PubMed ID: 29843004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).
    Lou SC; Pearce SK; Lukaszewska TX; Taylor RE; Williams GT; Leary TP
    J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays.
    Louisirirotchanakul S; Khupulsup K; Akraekthalin S; Chan KP; Saw S; Aw TC; Cho DH; Shin MG; Lim J
    J Med Virol; 2010 May; 82(5):755-62. PubMed ID: 20336717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection of early acute, late acute, and occult Hepatitis B infections by an increased sensitivity HBsAg assay.
    Kuhns MC; Holzmayer V; McNamara AL; Sickinger E; Schultess J; Cloherty GA
    J Clin Virol; 2019 Sep; 118():41-45. PubMed ID: 31442662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systems.
    Lunel-Fabiani F; Duburcq X; Levayer T; Descamps F; Maniez-Montreuil M; Pivert A; Ducancelle A; Pouzet A; Marant L; Clèment A; Duhamel D; Leirens Y; Margotteau F; Falcou-Briatte R; Heinen C; Bouniort F; Taskar S; Artus A; Woodrum D; Flecheux O
    Clin Lab; 2010; 56(7-8):281-90. PubMed ID: 20857892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
    van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
    Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
    Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBsAg blood screening and diagnosis: performance evaluation of the ARCHITECT HBsAg qualitative and ARCHITECT HBsAg qualitative confirmatory assays.
    Popp C; Krams D; Beckert C; Buenning C; Queirós L; Piro L; Luciani M; Roebbecke M; Kapprell HP
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):479-85. PubMed ID: 21658874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection.
    Yang L; Song LW; Fang LL; Wu Y; Ge SX; Li H; Yuan Q; Zhang J; Xia NS
    J Virol Methods; 2016 Feb; 228():55-9. PubMed ID: 26615806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C.
    Ryu JH; Kwon M; Moon JD; Hwang MW; Lee JM; Park KH; Yun SJ; Bae HJ; Choi A; Lee H; Jung B; Jeong J; Han K; Kim Y; Oh EJ
    Ann Lab Med; 2018 Nov; 38(6):578-584. PubMed ID: 30027702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the clinical performance of the ECLusys HBsAg II assay with the Lumipulse f and HISCL 2000-i HBsAg screening assays].
    Sugiura A; Iwahara K; Suga Y; Uchiyama S; Maekawa M
    Rinsho Byori; 2012 Feb; 60(2):103-9. PubMed ID: 22568090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reliability of HBV core antibody in serological screening for hepatitis B virus.
    Ba Alawi F; Robertson PW; LePage AK; Jayamaha J; Baleriola C; Rawlinson WD
    Pathology; 2013 Aug; 45(5):501-5. PubMed ID: 23842045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.
    Krawczyk A; Hintze C; Ackermann J; Goitowski B; Trippler M; Grüner N; Neumann-Fraune M; Verheyen J; Fiedler M
    J Clin Virol; 2014 Jan; 59(1):44-9. PubMed ID: 24268764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA; Stramer SL; Kuhns MC; Schlauder GG
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.
    Wursthorn K; Jaroszewicz J; Zacher BJ; Darnedde M; Raupach R; Mederacke I; Cornberg M; Manns MP; Wedemeyer H
    J Clin Virol; 2011 Apr; 50(4):292-6. PubMed ID: 21273117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg.
    Weber B; Dengler T; Berger A; Doerr HW; Rabenau H
    J Clin Microbiol; 2003 Jan; 41(1):135-43. PubMed ID: 12517838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.
    Takeda K; Maruki M; Yamagaito T; Muramatsu M; Sakai Y; Tobimatsu H; Kobayashi H; Mizuno Y; Hamaguchi Y
    J Clin Microbiol; 2013 Jul; 51(7):2238-44. PubMed ID: 23658266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance.
    Shinkai N; Matsuura K; Sugauchi F; Watanabe T; Murakami S; Iio E; Ogawa S; Nojiri S; Joh T; Tanaka Y
    J Clin Microbiol; 2013 Nov; 51(11):3484-91. PubMed ID: 23946517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.